NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- In
new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of Alexion
Pharmaceuticals, Inc. (ALXN), Plug Power,
Inc. (PLUG), Rayonier Advanced Materials
Inc. (RYAM), SunCoke Energy, Inc. (SXC), Rhythm Pharmaceuticals, Inc. (RYTM), and Armstrong Flooring, Inc. (AFI), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ALXN DOWNLOAD: http://MarketSourceResearch.com/register/?so=ALXN
PLUG DOWNLOAD: http://MarketSourceResearch.com/register/?so=PLUG
RYAM DOWNLOAD: http://MarketSourceResearch.com/register/?so=RYAM
SXC DOWNLOAD: http://MarketSourceResearch.com/register/?so=SXC
RYTM DOWNLOAD: http://MarketSourceResearch.com/register/?so=RYTM
AFI DOWNLOAD: http://MarketSourceResearch.com/register/?so=AFI
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Alexion Pharmaceuticals, Inc. (ALXN), Plug Power, Inc. (PLUG), Rayonier Advanced Materials Inc. (RYAM), SunCoke Energy, Inc. (SXC), Rhythm Pharmaceuticals, Inc. (RYTM), and Armstrong Flooring, Inc. (AFI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 5th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ALEXION PHARMACEUTICALS, INC. (ALXN) REPORT OVERVIEW
Alexion Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Alexion Pharmaceuticals reported revenue of $1,026.50MM vs $859.10MM (up 19.49%) and analysts estimated basic earnings per share $1.48 vs $0.35 (up 322.86%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Alexion Pharmaceuticals reported revenue of $3,551.10MM vs $3,084.10MM (up 15.14%) and analysts estimated basic earnings per share $1.98 vs $1.78 (up 11.24%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.53.
To read the full Alexion Pharmaceuticals, Inc. (ALXN) report, download it here: http://MarketSourceResearch.com/register/?so=ALXN
-----------------------------------------
PLUG POWER, INC. (PLUG) REPORT OVERVIEW
Plug Power's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Plug Power reported revenue of $53.17MM vs $34.59MM (up 53.69%) and analysts estimated basic earnings per share -$0.07 vs -$0.18. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Plug Power reported revenue of $103.26MM vs $85.93MM (up 20.17%) and analysts estimated basic earnings per share -$0.60 vs -$0.32. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is -$0.21 and is expected to report on March 6th, 2019.
To read the full Plug Power, Inc. (PLUG) report, download it here: http://MarketSourceResearch.com/register/?so=PLUG
-----------------------------------------
RAYONIER ADVANCED MATERIALS INC. (RYAM) REPORT OVERVIEW
Rayonier Advanced Materials' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Rayonier Advanced Materials reported revenue of $544.34MM vs $209.72MM (up 159.56%) and analysts estimated basic earnings per share $0.68 vs $0.29 (up 134.48%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Rayonier Advanced Materials reported revenue of $961.33MM vs $868.73MM (up 10.66%) and analysts estimated basic earnings per share $7.17 vs $1.61 (up 345.34%). Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.50. The estimated EPS forecast for the next fiscal year is $1.95 and is expected to report on February 13th, 2019.
To read the full Rayonier Advanced Materials Inc. (RYAM) report, download it here: http://MarketSourceResearch.com/register/?so=RYAM
-----------------------------------------
SUNCOKE ENERGY, INC. (SXC) REPORT OVERVIEW
SunCoke Energy's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, SunCoke Energy reported revenue of $364.50MM vs $339.00MM (up 7.52%) and basic earnings per share $0.18 vs $0.18 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, SunCoke Energy reported revenue of $1,331.50MM vs $1,223.30MM (up 8.84%) and analysts estimated basic earnings per share $1.90 vs $0.22 (up 763.64%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $0.61 and is expected to report on February 4th, 2020.
To read the full SunCoke Energy, Inc. (SXC) report, download it here: http://MarketSourceResearch.com/register/?so=SXC
-----------------------------------------
RHYTHM PHARMACEUTICALS, INC. (RYTM) REPORT OVERVIEW
Rhythm Pharmaceuticals' Recent Financial Performance
Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$2.56 and is expected to report on March 11th, 2019.
To read the full Rhythm Pharmaceuticals, Inc. (RYTM) report, download it here: http://MarketSourceResearch.com/register/?so=RYTM
-----------------------------------------
ARMSTRONG FLOORING, INC. (AFI) REPORT OVERVIEW
Armstrong Flooring's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Armstrong Flooring reported revenue of $309.70MM vs $308.50MM (up 0.39%) and analysts estimated basic earnings per share $0.31 vs -$0.70. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Armstrong Flooring reported revenue of $1,133.70MM vs $1,193.20MM (down 4.99%) and analysts estimated basic earnings per share -$1.54 vs $0.33. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is $0.53 and is expected to report on March 5th, 2019.
To read the full Armstrong Flooring, Inc. (AFI) report, download it here: http://MarketSourceResearch.com/register/?so=AFI
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.